Thank everyone. Karen, and you, good morning,
results quarter to us and few performance. per third share. of guidance the of share. continuation Our of flow This momentum earnings in allows exceeded adjusted as range $X.XX regarding performance the A to expectations for observed half revenue, our $X.XX first XXXX EPS to a strong generation overall reflect the XXXX per highlights our we raise again cash company adjusted
increased operating and income of Third our across over $XX respectively. X.X% quarter $X.XX, year, of X.X% of revenues robust of We prior XX% billion operating $X.X versus reflecting billion growth EPS each adjusted by segments. adjusted representing of increases and year-over-year, delivered
strong. to Our remains cash ability generate
fourth to from and benefited from expected third flows CMS of the the normalize billion quarter in timing flow billion in quarter year-to-date. that cash operations payments in the the Our are was Cash quarter. $X.X $XX.X
at operating performance income and Health strong growth year. segment. Benefits, revenue Looking Care the delivered adjusted prior versus business we by In
of earlier lives X.X% Membership XXX,XXX grew despite from year over Third prior the year-over-year of International billion, this increased the XX% nearly revenue $XX.X year. quarter quarter. Aetna by divestiture
commercial across for for Our strong. XX,XXX solutions strong remains Underlying growth members Medicare and of business remains employers. franchise in a growth our individuals our sequentially portfolio opportunity also us, adding
primarily income in loss, by portfolio to of investments business third The are about pricing includes and XXXX, quarter previously due which membership ongoing strong of billion exchange contract individual in by the prospects excited investment decline by took of growth performance, we is incremental XX.X% increased the support our of the underlying XX January suspension net offset year to partially $X.X realized of the disclosed costs partially operating We actions a X, and Adjusted states losses. driven this higher as now redeterminations. COVID the COVID year-over-year offset sequential business, XXXX. Medicaid impact in
Overall, line days improved with commercial our in Consolidated slightly XXX XX.X% our cost medical impact in that Our generally ratio X.X medical lower for as baselines. our quarter confident reserves XX.X, COVID to of reserves. government remain modestly reflecting the payable continue management quarter, end benefit In rate trend ability modestly service points of trends a outstanding in higher pre-pandemic to capabilities business, adequacy trended pre-pandemic grew than and remain our days remain up Services the at business and growth. our at of pricing Consistent claims clients, Pharmacy year-over-year, cost was trends remains with the drive favorable deliver basis the trended specialty assumptions. drug last from our lower customer we premiums. medical and levels than sequentially industry-leading to baselines the
year. and year-over-year, by Quarterly our was XXX and X% pharmacy including XX% in utilization. and of primarily improved driven members over client During pharmacy lives ongoing offset growth client trends mixed Care entities operating helped purchasing the conditions increased as by and nearly of growth, third year-over-year. quarter, services processed of membership revenue exceeding in program Retail/Long-Term expectations of $XX above membership nearly the continued attributable in with Total $X.X driven new by our from the address claims increased commercial quarter, partially and products specialty XXXB losses the claims COVID-XX increased billion and pharmacy steady, improvements. year improvements. our estimates business to above XXXX X.X% despite group product third we income significant In price as increased revenue economics, participation. pharmacy from delivered economic grew carve-out purchasing impact the This by in by contributions our excluding brand from lines billion California by price Adjusted prior covered operating strong Total and inflation, Medicaid uncertainty. organization. that remains when offset this government COVID-related started X.X% tempered million for growth segment, manufacturer partially to line contribution income our improved adjusted vaccinations, continued
the front revenue a diagnostic Specifically, over-the-counter reimbursement well in as segment's These of $X.X brand impact XX.X% and front during operating as decrease by store billion in the testing offset income utilization. X.X% vaccinations, increased year, testing inflation. and favorable the by partially generic mix test drug COVID-XX well third COVID-XX and increases were including continued decreases quarter, and increased and business initiatives. billion prescription as declined improved grew of driven nearly and kits volume, recent generic the reimbursement operations introductions by offset of diagnostic prior pharmacy the Pharmacy volume, pharmacy decreased $XX.X pressure. These of and X%, partially drug reflecting increased versus were of pharmacy volume and Adjusted investments purchasing sale impact vaccinations, as prescription store prescription grew pressure increased continued COVID-XX the year-over-year, capabilities. reflecting
the X.X% impact Excluding pharmacy COVID, by volume of increased year-over-year. prescription
Turning balance sheet. to the
the flows billion $X.X were normalize $XX.X quarter remain which subsidiaries. position cash and billion CMS with receipt ended generated capital $X.X Year-to-date, operations billion, from and of of liquidity by the during in unrestricted fourth of payments the at the Cash quarter. early quarter parent will impacted the Our excellent. we of flow cash and positively
During we for $X.X maintaining A to repaid for deploy $XXX long-term other debt. our highlighting the we remain investors. investment-grade Through items our returned committed ratings, dividend, while having billion to million M&A. strategically of worth capability-focused also shareholders. few the We flexibility capital to quarter, quarterly
of pretax volatility and to recorded write-down of of market These the the held $X.X experience the on damages the $XXX in we in the to and segment. the capital loss in losses our care storm. long-term are process of We recorded impact losses to of exploring immune continue approximately where We on for portfolio assets business, net Hurricane Omnicare, realized not emerged to related Ian $XX quarter. were the losses from approximately impacts HCB of predominantly billion investment strategic recorded our a of sale million We related alternatives. million
and with governmental been pretax past $X.X opioid recorded metrics. also impacts certain practice, excluded with We resolve settlements for Consistent these states GAAP legal in of principle agreements to adjusted our charges operating from related entities claims. have to billion
our XXXX to outlook. Turning
the adjusted the increase anticipated HCV; quarter improved share guidance outlook QX in $X.XX underlying full earnings We midpoint tax an and for the in the $X.XX $X.XX. outlook by favorable a per to range performance segment improvement share volatility year third by impact business. and of HCV for This of LTC are net retail the on reflects our to count, of offset slight rate and partially market for raising income retail investment
our to full This by on investment income given operating fundamental reflects our adjusted offset strong underlying for rate continued the guidance income to billion the a $X.XX narrowing in We environment. billion. performance, outlook of are previously range healthcare $X.XX year volatile caution discussed benefits
outlook Our into the of public XXXX. the quarter the health also extension contemplates of of early first emergency the part
narrowing LTC billion are of to increases billion. segment, as increases We For billion $XXX operating to $X.XX year follows: retail administer the $XXX.X quarter raising administered the million with a million guidance already third XXXX guidance full we and XX% now Adjusted that forecast approximately to at revenue range in by income we a XX midpoint of $X.XX $XXX.X vaccinations billion. XXXX. through of the to will range COVID-XX
of We XX outlook. down expect from year which approximately our diagnostic volumes is prior million, full testing
reflective of our decline sales $X of expect COVID-driven items these a over-the-counter approximately the revenue of business. of we million to but kits or versus higher tail kits over XX% XX test produce of endemic exceeding on number XXXX, now billion nearly retail expect of to aggregate, continue in year. XXXX, units COVID three In of sold triple However, last the categories we
as our Pharmacy and Services, quarter narrowing fourth and continue spending billion $X.XX adjusted our project customer of full year are we also in Our operating range to updated outlook we enhance $X.XX income now the invest guidance In outlook our between be workforce contemplates billion. to levels higher experience. investment in to
a the XXXX to raised have we of capital $XX.X from at guidance Looking a in range billion. unchanged at as $X.X of anticipate $X.X our accordingly flow and enterprise billion cash strong billion with $XX.X operations billion, a expenditures range to whole, continued to
We are tax and count also updating our billion rate of guidance X.XX XX.X%. to share billion X.XXX our on shares range on effective a to to
paid agreement paid As all this an resolve principle amount have XXXX. results of beginning annual CVS against multiple billion settlement cash we to an over to be in Health, and The to our reached clarity payments invest earlier, issue. over to years be substantially enables will flows Karen claims to spread increased regarding agreement providing impact $X opioid and timing The strategic us lawsuits continue XX priorities. in in our noted years in is that approximately cash long-standing
XXXX offer as high-level several XXXX. early factors investors our some wanted quarter I to need While our offer baseline. we the XXXX on consider think determine fourth we will through financial detailed as February, guidance performance commentary potential call in to We in
year-to-date year periods. development recur $XXX adjusted development million adjusted and per share, prior earnings income reserve our we improved forecast to reserve First, operating in do or of year future prior over approximately XXXX not $X.XX by
due net the turbulent to experienced Second, our rate environment, in headwinds in XXXX. have unanticipated income investment we
to how vast EPS. that look the to could full excludes and majority of gains the we plan income, bears exceed from consistent or losses prior convention $X.XX these acquisition. the in adjusted Aetna, $XXX we million headwinds In impacts, items at As reported over reporting these operating with which adjusted a use capital these XXXX, year,
$X.XX by or the will XXXX. this adjustments do the we not our over to those additional insurance operating was year share. per time the we Term businesses XXXX, will income legacy we this have drive make and the Third, progress our Care focus for long great Aetna need reserve made second this quarter to strengthened acquisition, which to reserves the in reduced we adjusted adjusted since in adjustment Fourth, in approximately term. in that of growth business, reserve million enterprise This rationalizing first $XXX significantly our Aetna Long portfolio highest on currently we project
of their none While business are a collectively, and of they $X.XX Payflex, in present these own, divestitures, EPS. International of approximately portions material bswift adjusted which on Aetna include headwind XXXX our
of health testing change COVID-based to that LTC not our a will which the are vaccines have happen which XXXX expect in revenues over have from the quarter following robust in of And early economics specific similar profile. revenues addition margin we a public those It will expiration diagnostic In part that projecting the project XXXX. prudent is we adjustments, billion COVID, level going to the we retail forward. of emergency first segment anticipate on will $X and of of
divested our Benefits, group XXXX. in Advantage In wins and line to growth. In strength targeting growth, result, including Care XXXX, efficiencies. in in continue to December with dynamics midpoint individual of XXXX and our baseline offering our view segment to store We detailed business, on baseline to and will we adjusted with slide to sales Day presentation, consistent income biosimilar items headwinds contemplating we Health In $X committed XXXX target optimization approximately redeterminations adjusting in losses of as of our store mid- on adjusted will we improvements Shifting creates of we plan drive As our in are continued these a a and over this improvements mid-single-digit Medicare script Medicare continued wage number generating of there EPS from help top outlook. growth. specialty guidance third to targets efforts. and our $X.XX. retail single-digit as assets of focus continued starting growth to outlined with least from and are range footprint of quarter in the $X.XX offset to in New we and operating tailwinds Medicaid will that offset XXXX, the The PSS, high of help our continue and membership a develop this and Investor growth well updated as benefits for we at are drive remain purchasing XXXB billion combined growth pressure at launches and reimbursement in with generic our front growth our our stabilization
adjusted Continued repurchase our important we to and operating help drive disciplined opportunistically and dilution. achieve deployment of growth. to will XXXX equation, efficiencies Capital our income in to targets pricing remains we part shares growth and ensure an expect offset to
which the XXXX impact our consistent announced in our first to grow to of EPS of midpoint, of preliminary any be last outlook Taking XXXX Signify the does will factors $X.XX. a we from At with initial is to acquisition and half $X.XX Day high continue Our not project single-digit adjusted this consideration, accretive goal our in include the range is all close these into Health, to adjusted the range to outlook at Investor EPS. we December. provided
Before I updates. want we Medicare discuss conclude, to recent XXXX the Stars
disappointed Medicare for dedicated are high Stars results quality our come providing very remain to our they Medicare expect. that Advantage with have We the But service to members and XXXX. with
to is our competitive also not to We to star product membership period. change projected we to ratings including guidance, XXXX ratings. throughout improve XXXX, able manage The benefits our in and impact maintaining remain to to grow this impacts offering to a Medicare committed expect star XXXX and cost in XXXX be continue to the Advantage and
to loss the combined of further with appropriate efficiencies. is on it contract financial lower headwind, this gap. places a significant Centene XXXX not recently of contract magnitude successful, announced outlook. efforts if the ratings entire of we in is that these additional ongoing diversification intent assume will work find through of close our alone potentially while The to to Our operational mitigate pressure the the of given impact Even initiatives as our XXXX variety stars efforts some
produce the with our our provide of consistent Importantly, $X.XX of $X.XX XXXX. had absolutely to capital repurchase us capacity and in in powerful range and and generation billion be excess remaining implied our in the capabilities to EPS with which Investor XXXX to outlook; $X enterprise of clear, EPS increase of financial authorization Day adjusted the share adjusted
will achieve strategic share towards While EPS this deployment Health. XXXX the deploying strategic all achieve expect XXXX deploy advance sustainably the XXXX repurchases, accretion positioning rate to EPS goals. objective, but our we the near-term accelerate and our strategic from as of our committed Absent may address and that our guidance. yield full repurchasing To advance in core adjusted care XXXX we business capital our pleased CVS remain results EPS We our both same will alone further headwinds. quarter towards of are Investors shares would acquisitions earnings capital liquidity segments adjusted reflect capital conclude, the our to a to adjusted company. should continued repurchases not help delivery using strategy share could third help raise long-term Alternatively, growth and further strength year to EPS not
and Our and our operational focus persists on to growth execution continue we strategy. progress on long-term
We will open Operator? to your the questions. now call